M. Brada
- Genetics top 0.1%
- Glioma Diagnosis and Treatment 59
-
- Pituitary Gland Disorders and Treatments 11
- Neurology top 1%
- CNS Lymphoma Diagnosis and Treatment 9
-
- Brain Metastases and Treatment 33
- Lung Cancer Treatments and Mutations 10
-
- Lymphoma Diagnosis and Treatment 23
-
- Meningioma and schwannoma management 14
-
- Advanced Radiotherapy Techniques 12
- Co-authors
- S. AshleyD. TraishRoger StuppGeorge PentheroudakisKumar B. RajanGiuseppe MinnitiMartin J. van den BentJ.-C. Tonn
- Journals
- Clinical Oncology (22 papers)Radiotherapy and Oncology (10 papers)European Journal of Cancer (9 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
M. Brada
119 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Genetics 3.8k
- Endocrinology, Diabetes and Metabolism 1.4k
- Neurology 1.2k
- Pulmonary and Respiratory Medicine 2.0k
- Pathology and Forensic Medicine 795
Countries citing papers authored by M. Brada
This map shows the geographic impact of M. Brada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Brada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Brada more than expected).
Fields of papers citing papers by M. Brada
This network shows the impact of papers produced by M. Brada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Brada. The network helps show where M. Brada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Brada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 16 | |
| 2 | High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upbreakdown → | 2014 | 570 |
| 3 | 2010 | 279 | |
| 4 | A RANDOMISED TRIAL OF PROCARBAZINE, CCNU AND VINCRISTINE (PCV) VS TEMOZOLOMIDE (5-DAY OR 21-DAY SCHEDULE) FOR RECURRENT HIGH GRADE GLIOMA (MRC BR12, ISRCTN83176944) | 2008 | 7 |
| 5 | 2006 | 16 | |
| 6 | 2004 | 72 | |
| 7 | 2003 | 188 | |
| 8 | Randomized trial of porcarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A medical research council trial | 2001 | 16 |
| 9 | 2000 | 64 | |
| 10 | 1999 | 44 | |
| 11 | Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in primary CNS lymphoma (PCL)- BR06. | 1998 | 1 |
| 12 | 1997 | 6 | |
| 13 | 1997 | 36 | |
| 14 | 1997 | 1 | |
| 15 | 1995 | 68 | |
| 16 | 1993 | 41 | |
| 17 | 1993 | 227 | |
| 18 | 1991 | 3 | |
| 19 | 1989 | 16 | |
| 20 | 1987 | 22 |
About M. Brada
M. Brada is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology, having authored 121 papers that have together received 6.7k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (59 papers), Brain Metastases and Treatment (33 papers), Lymphoma Diagnosis and Treatment (23 papers), Meningioma and schwannoma management (14 papers), Advanced Radiotherapy Techniques (12 papers), Pituitary Gland Disorders and Treatments (11 papers), Lung Cancer Treatments and Mutations (10 papers) and CNS Lymphoma Diagnosis and Treatment (9 papers). The work is most often cited by research in Genetics (3.8k citations), Endocrinology, Diabetes and Metabolism (1.4k citations) and Neurology (1.2k citations). M. Brada has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include S. Ashley, D. Traish, Roger Stupp, George Pentheroudakis, Kumar B. Rajan, Giuseppe Minniti, Martin J. van den Bent, J.-C. Tonn, David Osoba and W.K. Alfred Yung. Their work appears in journals such as Clinical Oncology, Radiotherapy and Oncology, European Journal of Cancer, British Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.